ORCID as entered in ROS

Select Publications
2008, 'EFFECT OF STEATOSIS ON THE INTRAHEPATIC CYTOKINE/CHEMOKINE RESPONSES IN CHRONIC HCV', in Hepatology, John Wiley & Sons Inc, Hoboken, NJ, USA, pp. 1080 - 1081, presented at Hepatology
,2008, 'High retinol binding protein-4 and low adiponectin levels are associated with steatosis in bariatric patients', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A285 - A285, presented at Journal of Gastroenterology and Hepatology
,2008, 'Preparedness for candidate hepatitis C vaccine trials in people who inject drugs: challenges and opportunities', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A358 - A358
,2008, 'Statins may aggravate liver injury in obese subjects with nonalcoholic fatty liver disease', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A283 - A283, presented at Journal of Gastroenterology and Hepatology
,2007, 'Polymorphisms in adrenergic receptors, adiponcetin and adiponectin receptors influence fibrosis rates and response to therapy in chronic HCV', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 440A - 440A, presented at 58th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 02 November 2007 - 06 November 2007, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249910400460&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2007, 'A pilot study to assess the impact of rosuvastatin therapy on HCV RNA and lipid fractions in chronic hepatitis c patients', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. A741 - A741, presented at Digestive Disease Week Meeting/108th Annual Meeting of the American-Gastroenterological-Association, DC, Washington, 19 May 2007 - 24 May 2007
,2005, 'A serum proteomic analysis in hepatitis C fibrosis', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. 117 - 117, presented at 40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, FRANCE, Paris, 13 April 2005 - 17 April 2005
,2005, 'Does ribavirin therapy select resistance mutations in HCV polymerase?', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. 226 - 226, presented at 40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, FRANCE, Paris, 13 April 2005 - 17 April 2005
,2003, 'Differential gene expression patterns in acute rejection associated with HCV recurrence post liver transplant', in LIVER TRANSPLANTATION, W B SAUNDERS CO, SPAIN, BARCELONA, pp. C36 - C36, presented at 9th Meeting of the International-Liver-Transplantation-Society/13th Meeting of the Liver-Intensive-Care-Group-of-Europe, SPAIN, BARCELONA, 18 June 2003 - 21 June 2003
,2014, 'Factors associated with medication adherence in patients living with cirrhosis', Boston, presented at American Association Society for Liver Disease (AASLD) Liver meeting, Boston, 07 November 2014 - 10 November 2014
,2022, 'MONITORING QUALITY OF CARE IN HEPATOCELLULAR CARCINOMA: A MODIFIED DELPHI CONSENSUS', in HEPATOLOGY, WILEY, Vol. 76, pp. S1311 - S1312, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000870796604144&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'EFFECT OF GUT INFLUENCE ON THE IMMUNE ENVIRONMENT IN PRE-CLINICAL HCC', in GUT, BMJ PUBLISHING GROUP, Vol. 71, pp. A5 - A5, http://dx.doi.org/10.1136/gutjnl-2022-IDDF.6
,2022, 'Effect of gut influence on the immune environment in preclinical hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 37, pp. 38 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852585700071&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Defining the temporal evolution of the gut microbiome and associated intrahepatic immune response in the Mdr2-/- model of hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 19 - 19, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Impact of the gut microbiome and metabolome on the peripheral immune response in non-alcoholic fatty liver disease-related hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 19 - 20, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Alterations in metabolic risk factor profile in the transition from non-alcoholic fatty liver disease (NAFLD) to NAFLD-related hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 58 - 58, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100091&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Outcomes based on plasma biomarkers for the Phase III CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 41 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Virtual clinic for positive fecal occult blood test result: Our local experience', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 238 - 238, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100377&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Factors associated with adherence to hepatocellular carcinoma surveillance in patients undergoing hepatitis B anti-viral therapy in Australia.', in HEPATOLOGY, WILEY, MA, Boston, Vol. 64, pp. 811A - 811A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 11 November 2016 - 15 November 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493804001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Predictors of non-adherence to HBV anti-viral therapy', in HEPATOLOGY, WILEY, MA, Boston, Vol. 64, pp. 812A - 812A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 11 November 2016 - 15 November 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493804004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2000, 'Hepatitis C Virus prevalence and genotype among Australian injecting drug users in the 1970s.', in HEPATOLOGY, W B SAUNDERS CO, Vol. 32, pp. 279A - 279A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000089622400468&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1999, 'The mechanisms of rumination and the role of lower esophageal sphincter (LES) relaxations.', in Gastroenterology, W B Saunders Co, Philadelphia, PA, USA, pp. A704 - A704, presented at Digestive Disease Week and the 99th Annual Meeting of the American Gastroenterological Association, New Orleans, Louisiana, USA, 17 May 1999 - 20 May 1999, http://dx.doi.org/10.1016/s0016-5085(98)82889-8
,2016, Knowledge of Treatment and Disease Questionnaire, http://dx.doi.org/10.1037/t51934-000
,2024, Multi-omics data integration for early diagnosis of hepatocellular carcinoma (HCC) using machine learning, http://dx.doi.org/10.1093/bib/bbaf116
,Artificial Intelligence Reliably Identifies Patients at Risk of HCC Recurrence 1-Year Post-Surgical Resection, http://dx.doi.org/10.2139/ssrn.4006151
,